TipRanks
Travere Therapeutics (DE:17R)
BERLIN:17R
Germany Market
17R
Travere Therapeutics
RESEARCH TOOLSreports

Travere Therapeutics (17R) Ratios

2 Followers

Travere Therapeutics Ratios

DE:17R's free cash flow for Q2 2026 was $0.99. For the 2026 fiscal year, DE:17R's free cash flow was decreased by $ and operating cash flow was $-0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.05 2.74 2.08 3.47 3.42
Quick Ratio
 3.99 2.70 2.04 3.41 3.39
Cash Ratio
 0.77 0.58 0.29 0.33 0.43
Solvency Ratio
 0.02 0.07 -0.52 -0.12 -0.41
Operating Cash Flow Ratio
 0.61 0.24 -1.18 -1.57 -1.31
Short-Term Operating Cash Flow Coverage
 15.04 0.00 -3.46 0.00 0.00
Net Current Asset Value
$ -159.70M$ -52.80M$ -118.35M$ 28.67M$ -143.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.77 0.54 0.68 0.51 0.61
Debt-to-Equity Ratio
 25.16 2.86 6.80 2.02 9.51
Debt-to-Capital Ratio
 0.96 0.74 0.87 0.67 0.90
Long-Term Debt-to-Capital Ratio
 0.96 0.73 0.84 0.65 0.90
Financial Leverage Ratio
 32.60 5.27 10.06 3.93 15.70
Debt Service Coverage Ratio
 0.06 1.98 -3.33 -28.80 -27.21
Interest Coverage Ratio
 -4.27 -5.85 -28.96 -34.25 -29.04
Debt to Market Cap
 0.11 0.09 0.28 0.57 0.28
Interest Debt Per Share
 6.70 3.81 5.23 5.60 6.56
Net Debt to EBITDA
 323.30 10.61 -1.29 -1.06 -1.15
Profitability Margins
Gross Profit Margin
94.41%97.89%96.68%92.12%95.96%
EBIT Margin
-9.74%-7.85%-132.66%-251.16%-292.47%
EBITDA Margin
0.26%4.53%-113.98%-224.63%-273.54%
Operating Profit Margin
-6.84%-12.80%-138.88%-267.24%-292.17%
Pretax Profit Margin
-11.34%-10.04%-137.45%-258.96%-302.54%
Net Profit Margin
-7.35%-5.21%-137.90%-76.70%-254.41%
Continuous Operations Profit Margin
-11.45%-10.24%-137.51%-259.11%-302.82%
Net Income Per EBT
64.80%51.85%100.32%29.62%84.09%
EBT Per EBIT
165.79%78.43%98.98%96.90%103.55%
Return on Assets (ROA)
-5.44%-4.22%-54.12%-14.12%-41.40%
Return on Equity (ROE)
-55.79%-22.25%-544.28%-55.47%-649.88%
Return on Capital Employed (ROCE)
-6.25%-14.11%-82.32%-63.52%-60.29%
Return on Invested Capital (ROIC)
-6.19%-13.95%-69.27%-63.02%-59.79%
Return on Tangible Assets
-6.51%-5.19%-65.60%-16.28%-48.39%
Earnings Yield
-0.76%-0.75%-23.40%-16.68%-20.77%
Efficiency Ratios
Receivables Turnover
 7.33 6.12 8.60 6.86 6.58
Payables Turnover
 4.41 0.42 0.33 0.27 0.26
Inventory Turnover
 4.22 1.76 1.25 1.22 0.98
Fixed Asset Turnover
 49.28 33.62 11.88 5.69 3.64
Asset Turnover
 0.74 0.81 0.39 0.18 0.16
Working Capital Turnover Ratio
 1.62 1.99 0.71 0.37 0.27
Cash Conversion Cycle
 53.52 -608.51 -774.56 -975.31 -998.78
Days of Sales Outstanding
 49.77 59.60 42.45 53.23 55.51
Days of Inventory Outstanding
 86.46 207.41 292.23 299.97 373.51
Days of Payables Outstanding
 82.70 875.52 1.11K 1.33K 1.43K
Operating Cycle
 136.23 267.01 334.67 353.19 429.01
Cash Flow Ratios
Operating Cash Flow Per Share
 0.99 0.42 -3.01 -3.77 -2.92
Free Cash Flow Per Share
 0.55 -0.23 -4.29 -4.33 -3.37
CapEx Per Share
 0.44 0.65 1.28 0.56 0.44
Free Cash Flow to Operating Cash Flow
 0.56 -0.54 1.43 1.15 1.15
Dividend Paid and CapEx Coverage Ratio
 2.25 0.65 -2.35 -6.73 -6.57
Capital Expenditure Coverage Ratio
 2.25 0.65 -2.35 -6.73 -6.57
Operating Cash Flow Coverage Ratio
 0.15 0.11 -0.59 -0.69 -0.46
Operating Cash Flow to Sales Ratio
 0.16 0.08 -1.02 -1.93 -1.70
Free Cash Flow Yield
0.90%-0.60%-24.65%-48.17%-16.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -136.82 -68.23 -4.27 -5.99 -4.81
Price-to-Sales (P/S) Ratio
 9.68 6.95 5.89 4.60 12.25
Price-to-Book (P/B) Ratio
 234.71 29.69 23.26 3.32 31.29
Price-to-Free Cash Flow (P/FCF) Ratio
 111.14 -167.32 -4.06 -2.08 -6.25
Price-to-Operating Cash Flow Ratio
 62.09 90.22 -5.79 -2.38 -7.20
Price-to-Earnings Growth (PEG) Ratio
 1.20 0.79 -0.02 0.09 -0.11
Price-to-Fair Value
 234.71 29.69 23.26 3.32 31.29
Enterprise Value Multiple
 4.03K 164.03 -6.46 -3.11 -5.63
Enterprise Value
 6.22B 3.64B 1.72B 1.01B 1.69B
EV to EBITDA
 4.03K 164.03 -6.46 -3.11 -5.63
EV to Sales
 10.53 7.43 7.36 6.98 15.41
EV to Free Cash Flow
 120.83 -178.89 -5.07 -3.15 -7.86
EV to Operating Cash Flow
 67.15 96.46 -7.23 -3.62 -9.05
Tangible Book Value Per Share
 -1.14 0.02 -0.57 1.30 -0.85
Shareholders’ Equity Per Share
 0.26 1.29 0.75 2.70 0.67
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.02 >-0.01 >-0.01 >-0.01
Revenue Per Share
 6.33 5.50 2.96 1.96 1.72
Net Income Per Share
 -0.46 -0.29 -4.08 -1.50 -4.37
Tax Burden
 0.65 0.52 1.00 0.30 0.84
Interest Burden
 1.16 1.28 1.04 1.03 1.03
Research & Development to Revenue
 0.38 0.42 1.21 1.69 2.08
SG&A to Revenue
 0.62 0.69 1.13 1.83 1.80
Stock-Based Compensation to Revenue
 0.10 0.09 0.16 0.30 0.35
Income Quality
 -1.37 -1.48 0.74 0.74 0.56
Currency in USD